Drapkin Kimberlee C (CIK 1340881) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy ABOS (35,500 shares), Sell KANT (13,794 shares), Buy KANT (12,500 shares), Sell KANT (4,706 shares), Buy KANT (6,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Acumen Pharmaceuticals, Inc. (ABOS) | Director | Buy | 35,500 | $0 |
| 2025-07-02 | KINETA, INC./DE (KANT) | Director | Sell | 13,794 | $0 |
| 2025-06-25 | KINETA, INC./DE (KANT) | Director | Buy | 12,500 | $7,625 |
| 2025-06-25 | KINETA, INC./DE (KANT) | Director | Sell | 4,706 | $1,224 |
| 2025-06-25 | KINETA, INC./DE (KANT) | Director | Buy | 6,000 | $0 |
| 2025-06-05 | Acumen Pharmaceuticals, Inc. (ABOS) | Director | Buy | 12,800 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05